Iber T, Hecker K, Vagts D A, Roesner J P, Otto B, Steinicke A, Nöldge-Schomburg G F E, Rossaint R
Department of Anesthesiology and Intensive Care Medicine, University of Rostock, Rostock, Germany.
Minerva Anestesiol. 2008 Oct;74(10):511-9.
Over the last 15 years, there has been growing interest in the noble gas xenon as a new inhalational anesthetic. This is due to its favorable pharmacological properties such as short onset and offset, as well as its hemodynamic stability. However, most volatile anesthetics appear to play an important role in the multi-factorial etiology of perioperative liver injury by decreasing liver blood flow with a subsequent reduction of hepatic oxygen supply. However, the effects of the anesthetic gas xenon on hepatic perfusion and oxygenation have not been completely investigated.
Following ethical approval, 18 anesthetized and acutely monitored pigs were randomly assigned to the two following groups: 9 animals received xenon anesthesia in increasing inspiratory concentrations of 0%, 20%, 50%, and 65% in addition to their basic intravenous anesthesia; 9 animals served as a control group. Measurement points for systemic and regional hemodynamic and oxygenation parameters were performed 30 min after changing the xenon concentration.
Xenon elicited dose-dependent systemic hemodynamic changes such that the mean arterial pressure did not change, while the heart rate and cardiac output decreased by about 30%, thereby indicating an increase in the systemic vascular resistance. Portal venous blood flow decreased, while hepatic arterial blood flow was unchanged. The oxygen supply of the liver was reduced, but not the rate of indocyanine plasma disappearance from the liver. Furthermore, the increase of liver surface pO2 to systemic hyperoxia was absent, and hepatic lactate uptake was reduced.
Xenon, in addition to basic intravenous anesthesia, elicited a decrease in heart rate and cardiac output and an increase in mean arterial pressure. Similar to volatile anesthetics, xenon does reduce portal venous flow and influences hepatic tissue oxygenation. In contrast, hepatic arterial blood flow remains stable in the presence of xenon, and no changes in the hepatic arterial buffer responses were evident. Xenon does affect hepatic perfusion and oxygenation.
在过去15年里,作为一种新型吸入麻醉剂,稀有气体氙引起了越来越多的关注。这归因于其良好的药理学特性,如起效和消退迅速,以及血流动力学稳定性。然而,大多数挥发性麻醉剂似乎在围手术期肝损伤的多因素病因中起重要作用,因为它们会减少肝血流量,进而降低肝脏的氧气供应。然而,麻醉气体氙对肝脏灌注和氧合的影响尚未得到充分研究。
在获得伦理批准后,将18只接受麻醉并进行急性监测的猪随机分为以下两组:9只动物在基础静脉麻醉的基础上,吸入浓度递增的0%、20%、50%和65%的氙进行麻醉;9只动物作为对照组。在改变氙浓度30分钟后,测量全身和局部血流动力学及氧合参数。
氙引起剂量依赖性的全身血流动力学变化,平均动脉压不变,而心率和心输出量下降约30%,这表明全身血管阻力增加。门静脉血流量减少,而肝动脉血流量不变。肝脏的氧气供应减少,但肝脏中吲哚菁绿血浆清除率未降低。此外,肝脏表面pO2未因全身高氧而增加,肝脏乳酸摄取减少。
除基础静脉麻醉外,氙还会导致心率和心输出量下降,平均动脉压升高。与挥发性麻醉剂类似,氙确实会减少门静脉血流量并影响肝组织氧合。相比之下,在氙存在的情况下,肝动脉血流量保持稳定,且肝动脉缓冲反应无明显变化。氙确实会影响肝脏灌注和氧合。